| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,976 |
19,844 |
$2.14M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,073 |
11,716 |
$1.60M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
14,624 |
11,022 |
$403K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,802 |
2,796 |
$317K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,677 |
2,675 |
$303K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,149 |
2,106 |
$273K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,025 |
3,832 |
$213K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,955 |
1,939 |
$205K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,189 |
1,189 |
$149K |
| 99493 |
|
947 |
944 |
$142K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
15,207 |
13,576 |
$120K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,559 |
1,527 |
$78K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,881 |
1,846 |
$64K |
| 99494 |
|
716 |
713 |
$59K |
| 96127 |
|
7,482 |
5,393 |
$47K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,891 |
2,264 |
$30K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,838 |
949 |
$28K |
| 92552 |
|
781 |
776 |
$26K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
297 |
293 |
$22K |
| 99177 |
|
850 |
844 |
$16K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
612 |
610 |
$14K |
| 87428 |
|
209 |
209 |
$13K |
| 0072A |
|
296 |
296 |
$12K |
| 0002A |
|
290 |
290 |
$11K |
| 0071A |
|
262 |
261 |
$10K |
| 96160 |
|
13,707 |
8,817 |
$9K |
| 0001A |
|
247 |
247 |
$9K |
| 99051 |
|
2,566 |
2,534 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
736 |
728 |
$4K |
| 0004A |
|
97 |
96 |
$4K |
| 99173 |
|
272 |
270 |
$4K |
| 97803 |
|
77 |
54 |
$3K |
| 83655 |
|
93 |
93 |
$1K |
| 87081 |
|
265 |
262 |
$1K |
| 90461 |
|
2,211 |
2,050 |
$951.85 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
46 |
45 |
$859.06 |
| 85018 |
|
293 |
291 |
$605.79 |
| 96161 |
|
461 |
453 |
$603.74 |
| 90651 |
|
70 |
70 |
$554.78 |
| 0154A |
|
13 |
13 |
$520.00 |
| 90686 |
|
3,833 |
3,795 |
$519.40 |
| 90697 |
|
12 |
12 |
$498.78 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
29 |
29 |
$409.75 |
| 90480 |
|
12 |
12 |
$360.00 |
| 80061 |
Lipid panel |
37 |
37 |
$336.94 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
15 |
15 |
$305.69 |
| 99050 |
|
82 |
82 |
$301.86 |
| 90715 |
|
71 |
71 |
$127.37 |
| 81025 |
|
26 |
26 |
$82.40 |
| 92558 |
|
71 |
70 |
$69.43 |
| 90656 |
|
323 |
323 |
$62.08 |
| 81003 |
|
14 |
13 |
$28.04 |
| 90680 |
|
90 |
90 |
$17.85 |
| 36416 |
|
292 |
282 |
$6.32 |
| 90670 |
|
290 |
278 |
$0.00 |
| 90671 |
|
148 |
148 |
$0.00 |
| 91300 |
|
104 |
103 |
$0.00 |
| 90685 |
|
135 |
135 |
$0.00 |
| 90633 |
|
62 |
56 |
$0.00 |
| 99072 |
|
17 |
17 |
$0.00 |
| 90734 |
|
57 |
57 |
$0.00 |
| 3008F |
|
4,183 |
4,165 |
$0.00 |
| 99000 |
|
1,341 |
1,309 |
$0.00 |
| 91307 |
|
56 |
52 |
$0.00 |
| 90698 |
|
40 |
40 |
$0.00 |
| 90716 |
|
17 |
12 |
$0.00 |
| 90619 |
|
14 |
14 |
$0.00 |